Download - 1 Staphylococci

Transcript
  • 8/13/2019 1 Staphylococci

    1/19

    BatterjeeMedical College

  • 8/13/2019 1 Staphylococci

    2/19

    BatterjeeMedical College

    Dr. Manal El SaidHead of M icrobiology Department

    Staphylococc i

    Staphylococcus aureus

  • 8/13/2019 1 Staphylococci

    3/19

    BatterjeeMedical College

    Staphylococcus aureus

    Diseases

    -lactamase

    Toxic shock syndrome

    Abscesses of many organs

    Endocarditis

    Gastroenteritis (food poisoning)

    Hospital-acquired pneumonia

    Surgical wound infections

    Sepsis.

  • 8/13/2019 1 Staphylococci

    4/19

    BatterjeeMedical College

    Staphylococcus aureus

    Habitat and Transmission

    Characteristics Gram-positive cocci in clusters.

    Coagulase-positive.

    Catalase-positive.

    Most isolates produce-lactamase

    -lactamase.

    Main habitat is human nose & skin.

    Transmission is via the hands.

  • 8/13/2019 1 Staphylococci

    5/19

    BatterjeeMedical College

    Pathogenesis

    Staphylococcus aureus

    Three exotoxins:

    1-Toxic shock syndrome toxin

    -Superantigen helper T cells release of

    lymphokines ( IL-2).

    2- Enterotoxin

    - Superantigen

    - Food poisoning (has a short incubation period because it

    is preformed in food).3-Scalded skin syndrome toxin:

    - Protease cleaves desmoglein in tight junctions in skin.

    - Protein A binds to heavy chain of IgG & prevents

    activation of complement.

  • 8/13/2019 1 Staphylococci

    6/19

    BatterjeeMedical College

    Pathogenesis

    Staphylococcus aureus

    Abscesscontaining pusis the most common lesion.

    Predisposing factors to infection

    - Breaks in the skin

    - Foreign bodies such as sutures

    - Neutrophil levels below 500/ml

    - Intravenous drug use right-sided endocarditis

    - Tampon use toxic shock syndrome

  • 8/13/2019 1 Staphylococci

    7/19

    BatterjeeMedical College

    Laboratory Diagnosis

    Staphylococcus aureus

    Gram-stained smear and culture.

    Yellow or gold colonies on blood agar.

    Coagulase-positive

  • 8/13/2019 1 Staphylococci

    8/19

    BatterjeeMedical College

    Laboratory Diagnosis

    Staphylococcus aureus

  • 8/13/2019 1 Staphylococci

    9/19

    BatterjeeMedical College

    Staphylococcus aureus

    Treatment

    ;

    Penicillin G for sensitive isolates

    Nafcillin(-lactamaseresistant penicillins) for resistant

    isolates

    Vancomycinfor isolates resistant to nafcillin (changes in

    binding proteins).

    About 85% are resistant to penicillin G (tolerant to penicillin)

    Plasmid-encoded -lactamasemediates most resistance.

  • 8/13/2019 1 Staphylococci

    10/19

    BatterjeeMedical College

    S. aureus methicillin-resistant (MRSA) is due to altered

    penicillin-binding proteins.

    MRSA can produce outbreaks of disease, especially in

    hospitals.

    The drug of choice is vancomycin, to which gentamicin is

    sometimes added.

    Daptomycinis also useful.

    S. aureusmethicillin-resistant

    (MRSA)

    Treatment

  • 8/13/2019 1 Staphylococci

    11/19

    BatterjeeMedical College

    Trimethoprim-sulfamethoxazole or clindamycin can be used

    to treat nonlife-threatening infections caused by these

    organisms.

    MRSA strains are resistant to all -lactam drugs, including

    both penicillins & cephalosporins.

    Treatment

    S. aureusmethicillin-resistant

    (MRSA)

  • 8/13/2019 1 Staphylococci

    12/19

    BatterjeeMedical College

    S. aureuswith intermediate

    resistance to vancomycin

    Treatment Strains of S. aureus with intermediate resistance to

    vancomycin (VISA) & with complete resistance to

    vancomycin (VRSA) isolated from patients.

    These strains are methicillin-resistantas well, which makes

    them very difficult to treat.

    Daptomycin can be used to treat these infections

    Quinupristin-dalfopristin is another useful choice.

  • 8/13/2019 1 Staphylococci

    13/19

    BatterjeeMedical College

    Staphylococcus aureus

    Prevention

    ;

    Cefazolinis used to prevent surgical wound infections.

    No vaccine is available.

    Handwashing reduces spread.

    B j M di l C ll

  • 8/13/2019 1 Staphylococci

    14/19

    BatterjeeMedical College

    Diseases

    Characteristics

    Staphylococcus epiderm id is

    Endocarditison prosthetic heart valves

    Prosthetic hip infection

    Intravascular catheter infection

    Cerebrospinal fluid shunt infection

    Neonatal sepsis.

    Gram-positive cocci in clusters.

    Coagulase-negative.

    Catalase-positive.

    B tt j M di l C ll

  • 8/13/2019 1 Staphylococci

    15/19

    BatterjeeMedical College

    Pathogenesis

    Habitat and Transmission

    Staphylococcus epiderm idis

    Normal flora of human skin & mucous membranes.

    Patient's own strains cause infection

    Transmission from person to person via hands.

    Glycocalyx-producing strains adhere well to foreign bodies

    such as prosthetic implants & catheters. It is low-virulence organism that causes disease:

    - Immunocompromised patients

    - Those with implants.

    It is a major cause of hospital-acquired infections.

    B tt j M di l C ll

  • 8/13/2019 1 Staphylococci

    16/19

    BatterjeeMedical College

    Laboratory Diagnosis

    Staphylococcus epiderm idis

    Gram-stained smear and culture.

    Whitish, nonhemolytic colonies on blood agar.

    Coagulase-negative.

    Itis sensitive to novobiocin (S. saprophyt icus,is resistant).

    B tt j M di l C ll

  • 8/13/2019 1 Staphylococci

    17/19

    BatterjeeMedical College

    Laboratory Diagnosis

    Staphylococcus epiderm idis

    Batterjee Medical College

  • 8/13/2019 1 Staphylococci

    18/19

    BatterjeeMedical College

    Treatment

    Staphylococcus epiderm idis

    Vancomycinplus either rifampinor aminoglycoside.

    It produces -lactamases & is resistant to many antibiotics.

    Prevention

    There is no drug or vaccine.

  • 8/13/2019 1 Staphylococci

    19/19